Tan L, Tran B, Tie J, Markman B, et al. Phase Ib/II Trial of BRAF and EGFR inhibition in BRAFV600E metastatic colorectal cancer and other cancers: EVICT (Erlotinib and Vemurafenib In Combination Trial). Clin Cancer Res 2023 Jan 13:CCR-22-3094. doi: 10.1158/1078-0432.CCR-22-3094.
PMID: 36638198